Next Article in Journal
A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
Next Article in Special Issue
KLF10 as a Tumor Suppressor Gene and Its TGF-β Signaling
Previous Article in Journal
Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML
 
 
Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.
Review

Article Versions Notes

Cancers 2018, 10(6), 159; https://doi.org/10.3390/cancers10060159
Action Date Notes Link
article xml file uploaded 25 May 2018 10:50 CEST Original file -
article xml uploaded. 25 May 2018 10:50 CEST Update https://www.mdpi.com/2072-6694/10/6/159/xml
article pdf uploaded. 25 May 2018 10:50 CEST Version of Record https://www.mdpi.com/2072-6694/10/6/159/pdf
article html file updated 25 May 2018 10:51 CEST Original file -
article html file updated 25 June 2018 11:48 CEST Update -
article html file updated 30 March 2019 04:34 CET Update -
article html file updated 16 April 2019 17:11 CEST Update -
article html file updated 30 April 2019 16:44 CEST Update -
article html file updated 3 October 2019 23:04 CEST Update -
article html file updated 9 February 2020 19:01 CET Update -
article html file updated 16 July 2022 20:43 CEST Update https://www.mdpi.com/2072-6694/10/6/159/html
Back to TopTop